{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:14:03Z","timestamp":1792696443771,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Several pieces of evidence suggest that certain pathobionts belonging to Enterobacterales are associated with the development and progression of inflammatory bowel diseases (IBD). Extended-spectrum \u03b2-lactamases (ESBLs) ESBLs are frequently found in the Enterobacterales members, particularly in <jats:italic>Escherichia coli<\/jats:italic> and <jats:italic>Klebsiella<\/jats:italic> spp., and might trigger antibiotic-induced perturbations of the intestinal microbiota and led to more severe disease activity in IBD. Therefore, the severity of IBD could be influenced by ESBL-producing Enterobacterales, and hence, this study aimed to investigate the presence of ESBLs and carbapenemases among mucosa-associated <jats:italic>E. coli<\/jats:italic> and <jats:italic>Klebsiella pneumoniae<\/jats:italic> isolated from colonic biopsies of Iranian patients with IBD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this cross-sectional study, <jats:italic>E. coli<\/jats:italic> and <jats:italic>K. pneumoniae<\/jats:italic> were isolated from inflamed ileum and\/or colon tissue of patients with IBD, including Ulcerative colitis (UC) and Crohn\u2019s disease (CD), during colonoscopy. Demographic data and clinical characteristics were recorded, and UC and CD disease activity and extent were evaluated according to the full Mayo score and Crohn\u2019s disease activity index (CDAI), respectively. Phenotypic and molecular detection of ESBL- and carbapenemase-producing <jats:italic>E. coli<\/jats:italic> and <jats:italic>Klebsiella pneumoniae<\/jats:italic> were carried out. Disease activity and other clinical and microbial features were compared in patients with and without gut colonization with ESBL producers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 83 IBD patients, including 67 UC and 16 CD, were enrolled in the initial analysis. Intestinal colonization with ESBL-producing <jats:italic>E. coli<\/jats:italic> and\/or <jats:italic>Klebsiella pneumoniae<\/jats:italic> was found in 37 (55.2%) of UC and 9 (56.2%) of DC patients \u2013 mostly harbored <jats:italic>E. coli<\/jats:italic> containing the <jats:italic>bla<\/jats:italic><jats:sub>CTX\u2212M<\/jats:sub> and <jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub> genes. UC patients with intestinal colonization with ESBL-producers had more severe disease compared with patients without colonization. Moreover, 10.2% of tested <jats:italic>E. coli<\/jats:italic> and 34.8% of <jats:italic>K. pneumoniea<\/jats:italic> were recognized as potential carbapenemase producers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Intestinal colonization with ESBL producers could arise disease activity in IBD patients. Further large-scale case-control studies should be performed to investigate the possible confounding factors that could contribute to this outcome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12941-023-00630-x","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:01:48Z","timestamp":1694718108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["High prevalence of Mucosa-Associated extended-spectrum \u03b2-Lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with inflammatory bowel disease (IBD)"],"prefix":"10.1186","volume":"22","author":[{"given":"Ayda Afshari","family":"Kharaghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Harzandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Khorsand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Rajabnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azin Afshari","family":"Kharaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Houri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"issue":"10","key":"630_CR1","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1172\/JCI72330","volume":"124","author":"SR Dalal","year":"2014","unstructured":"Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest. 2014;124(10):4190\u20136.","journal-title":"J Clin Invest"},{"issue":"1","key":"630_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, et al. Ulcerative colitis. Nat Reviews Disease Primers. 2020;6(1):74.","journal-title":"Nat Reviews Disease Primers"},{"issue":"10080","key":"630_CR3","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756\u201370.","journal-title":"Lancet"},{"issue":"1","key":"630_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s13244-014-0377-6","volume":"6","author":"A Athanasakos","year":"2015","unstructured":"Athanasakos A, Mazioti A, Economopoulos N, Kontopoulou C, Stathis G, Filippiadis D, et al. Inflammatory bowel disease\u2014the role of cross-sectional imaging techniques in the investigation of the small bowel. Insights into Imaging. 2015;6(1):73\u201383.","journal-title":"Insights into Imaging"},{"issue":"1","key":"630_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/gutjnl-2016-312518","volume":"67","author":"M Weiser","year":"2018","unstructured":"Weiser M, Simon JM, Kochar B, Tovar A, Israel JW, Robinson A, et al. Molecular classification of Crohn\u2019s disease reveals two clinically relevant subtypes. Gut. 2018;67(1):36\u201342.","journal-title":"Gut"},{"issue":"4","key":"630_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/00365521.2018.1447597","volume":"53","author":"B Ahluwalia","year":"2018","unstructured":"Ahluwalia B, Moraes L, Magnusson MK, \u00d6hman L. Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol. 2018;53(4):379\u201389.","journal-title":"Scand J Gastroenterol"},{"key":"630_CR7","doi-asserted-by":"crossref","unstructured":"Khorsand B, Asadzadeh Aghdaei H, Nazemalhosseini-Mojarad E, Nadalian B, Nadalian B, Houri H. Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn\u2019s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets. Front Cell Infect Microbiol. 2022;12.","DOI":"10.3389\/fcimb.2022.1015890"},{"issue":"10","key":"630_CR8","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1128\/IAI.00319-08","volume":"76","author":"I Sekirov","year":"2008","unstructured":"Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun. 2008;76(10):4726\u201336.","journal-title":"Infect Immun"},{"key":"630_CR9","doi-asserted-by":"crossref","unstructured":"Castanheira M, Simner PJ, Bradford PA. Extended-spectrum \u03b2-lactamases: an update on their characteristics, epidemiology and detection. JAC-Antimicrobial Resist. 2021;3(3).","DOI":"10.1093\/jacamr\/dlab092"},{"issue":"8","key":"630_CR10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.cmi.2019.03.030","volume":"25","author":"B Guti\u00e9rrez-Guti\u00e9rrez","year":"2019","unstructured":"Guti\u00e9rrez-Guti\u00e9rrez B, Rodr\u00edguez-Ba\u00f1o J. Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients. Clin Microbiol Infect. 2019;25(8):932\u201342.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"630_CR11","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1155\/2013\/609230","volume":"24","author":"A Vaisman","year":"2013","unstructured":"Vaisman A, Pivovarov K, McGeer A, Willey B, Borgundvaag B, Porter V, et al. Prevalence and incidence of antimicrobial-resistant organisms among hospitalized inflammatory bowel disease patients. Can J Infect Dis Med Microbiol. 2013;24(4):e117\u201321.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"630_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","volume":"7","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013;7(2):107\u201312.","journal-title":"J Crohns Colitis"},{"issue":"10","key":"630_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.crohns.2013.06.001","volume":"7","author":"F Magro","year":"2013","unstructured":"Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7(10):827\u201351.","journal-title":"J Crohns Colitis"},{"key":"630_CR14","doi-asserted-by":"publisher","first-page":"588173","DOI":"10.3389\/fvets.2020.588173","volume":"7","author":"P Li","year":"2020","unstructured":"Li P, Zhang D, Li H, Pang J, Guo H, Qiu J. Establishment and application of Multiplex PCR for simultaneously detecting Escherichia coli, Salmonella, Klebsiella pneumoniae, and Staphylococcus aureus in Minks. Front Vet Sci. 2020;7:588173.","journal-title":"Front Vet Sci"},{"key":"630_CR15","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 30 ed2021."},{"issue":"9","key":"630_CR16","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3201\/eid1809.120355","volume":"18","author":"P Nordmann","year":"2012","unstructured":"Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):1503\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"630_CR17","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1128\/JCM.02032-15","volume":"53","author":"F Pasteran","year":"2015","unstructured":"Pasteran F, Tijet N, Melano RG, Corso A. Simplified protocol for Carba NP Test for enhanced detection of Carbapenemase Producers directly from bacterial cultures. J Clin Microbiol. 2015;53(12):3908\u201311.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"630_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/jac\/dkp498","volume":"65","author":"C Dallenne","year":"2010","unstructured":"Dallenne C, Da Costa A, Decr\u00e9 D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important \u03b2-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"630_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12941-015-0079-z","volume":"14","author":"NT Trung","year":"2015","unstructured":"Trung NT, Hien TT, Huyen TT, Quyen DT, Binh MT, Hoan PQ, et al. Simple multiplex PCR assays to detect common pathogens and associated genes encoding for acquired extended spectrum betalactamases (ESBL) or carbapenemases from surgical site specimens in Vietnam. Ann Clin Microbiol Antimicrob. 2015;14:23.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"630_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/CEG.S186235","volume":"12","author":"C Olbj\u00f8rn","year":"2019","unstructured":"Olbj\u00f8rn C, Cvancarova Sm\u00e5stuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Jahnsen J, et al. Fecal microbiota profiles in treatment-na\u00efve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome. Clin Exp Gastroenterol. 2019;12:37\u201349.","journal-title":"Clin Exp Gastroenterol"},{"issue":"9","key":"630_CR21","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):R79.","journal-title":"Genome Biol"},{"issue":"4","key":"630_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrgastro.2012.14","volume":"9","author":"I Mukhopadhya","year":"2012","unstructured":"Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol. 2012;9(4):219\u201330.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"630_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijantimicag.2018.12.006","volume":"53","author":"P Piewngam","year":"2019","unstructured":"Piewngam P, Qui\u00f1ones M, Thirakittiwatthana W, Yungyuen T, Otto M, Kiratisin P. Composition of the intestinal microbiota in extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand. Int J Antimicrob Agents. 2019;53(4):435\u201341.","journal-title":"Int J Antimicrob Agents"},{"key":"630_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jgar.2019.01.020","volume":"18","author":"R Beigverdi","year":"2019","unstructured":"Beigverdi R, Jabalameli L, Jabalameli F, Emaneini M. Prevalence of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae: first systematic review and meta-analysis from Iran. J Global Antimicrob Resist. 2019;18:12\u201321.","journal-title":"J Global Antimicrob Resist"},{"issue":"1","key":"630_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12879-022-07304-7","volume":"22","author":"S Aghamohammad","year":"2022","unstructured":"Aghamohammad S, Nikbin VS, Badmasti F, Shahcheraghi F. High heterogeneity of fecal carriage extended-spectrum beta-lactamase-producing E. coli isolated from iranian community and clinical settings. BMC Infect Dis. 2022;22(1):318.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"630_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/MEG.0000000000000989","volume":"30","author":"V Skuja","year":"2018","unstructured":"Skuja V, Derovs A, Pekarska K, Rudzite D, Lavrinovica E, Piekuse L, et al. Gut colonization with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae may increase disease activity in biologic-naive outpatients with ulcerative colitis: an interim analysis. Eur J Gastroenterol Hepatol. 2018;30(1):92\u2013100.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"630_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.crohns.2011.12.005","volume":"6","author":"W Leung","year":"2012","unstructured":"Leung W, Malhi G, Willey BM, McGeer AJ, Borgundvaag B, Thanabalan R, et al. Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population. J Crohns Colitis. 2012;6(7):743\u20139.","journal-title":"J Crohns Colitis"},{"issue":"11","key":"630_CR28","doi-asserted-by":"publisher","first-page":"e857","DOI":"10.1016\/S2666-5247(22)00181-1","volume":"3","author":"LW Roberts","year":"2022","unstructured":"Roberts LW, Hoi LT, Khokhar FA, Hoa NT, Giang TV, Bui C, et al. Genomic characterisation of multidrug-resistant < em > Escherichia coli, Klebsiella pneumoniae, and < em > Acinetobacter baumannii in two intensive care units in Hanoi, Viet Nam: a prospective observational cohort study. The Lancet Microbe. 2022;3(11):e857\u2013e66.","journal-title":"The Lancet Microbe"},{"key":"630_CR29","doi-asserted-by":"crossref","unstructured":"Ibrahim DR, Dodd CER, Stekel DJ, Meshioye RT, Diggle M, Lister M et al. Multidrug-resistant ESBL-Producing E. coli in Clinical samples from the UK. Antibiot (Basel). 2023;12(1).","DOI":"10.3390\/antibiotics12010169"},{"issue":"1","key":"630_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13099-021-00408-6","volume":"13","author":"J Gruszecka","year":"2021","unstructured":"Gruszecka J, Filip R. Are hospitalized patients with inflammatory bowel disease at increased risk of invasive bacterial infections? Results from POLIBD 3-year cohort study. Gut Pathog. 2021;13(1):12.","journal-title":"Gut Pathog"},{"issue":"6","key":"630_CR31","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/microorganisms9061282","volume":"9","author":"L Joseph","year":"2021","unstructured":"Joseph L, Merciecca T, Forestier C, Balestrino D, Miquel S. From Klebsiella pneumoniae colonization to dissemination: an overview of studies implementing murine models. Microorganisms. 2021;9(6):1282.","journal-title":"Microorganisms"},{"issue":"1","key":"630_CR32","doi-asserted-by":"publisher","first-page":"1940792","DOI":"10.1080\/19490976.2021.1940792","volume":"13","author":"R Th\u00e4nert","year":"2021","unstructured":"Th\u00e4nert R, Th\u00e4nert A, Ou J, Bajinting A, Burnham C-AD, Engelstad HJ, et al. Antibiotic-driven intestinal dysbiosis in pediatric short bowel syndrome is associated with persistently altered microbiome functions and gut-derived bloodstream infections. Gut Microbes. 2021;13(1):1940792.","journal-title":"Gut Microbes"},{"key":"630_CR33","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy C. Infectious diseases society of america antimicrobial resistant treatment guidance: gram-negative bacterial infections. Practice. 2020;6(8)."},{"issue":"Supplement7","key":"630_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cid\/ciz830","volume":"69","author":"Y Doi","year":"2019","unstructured":"Doi Y. Treatment Options for Carbapenem-resistant Gram-negative bacterial infections. Clin Infect Dis. 2019;69(Supplement7):565\u2013S75.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"630_CR35","doi-asserted-by":"publisher","first-page":"e01906","DOI":"10.1128\/spectrum.01906-21","volume":"10","author":"W Yuan","year":"2022","unstructured":"Yuan W, Xu J, Guo L, Chen Y, Gu J, Zhang H, et al. Clinical risk factors and microbiological and intestinal characteristics of carbapenemase-producing < i > Enterobacteriaceae colonization and subsequent infection. Microbiol Spectr. 2022;10(6):e01906\u201321.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"630_CR36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.chom.2010.08.004","volume":"8","author":"WS Garrett","year":"2010","unstructured":"Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe. 2010;8(3):292\u2013300.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"630_CR37","doi-asserted-by":"publisher","first-page":"1979882","DOI":"10.1080\/19490976.2021.1979882","volume":"13","author":"H Chandra","year":"2021","unstructured":"Chandra H, Sharma KK, Tuovinen OH, Sun X, Shukla P. Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile. Gut Microbes. 2021;13(1):1979882.","journal-title":"Gut Microbes"},{"issue":"4","key":"630_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657\u201386.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"630_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1469-0691.2004.00723.x","volume":"10","author":"V Tolun","year":"2004","unstructured":"Tolun V, K\u00fc\u00e7\u00fckbasmaci \u00d6, T\u00f6r\u00fcmk\u00fcney-Akbulut D, \u00c7atal \u00c7, An\u011f-K\u00fc\u00e7\u00fcker M, Au\u011f \u00d6. Relationship between ciprofloxacin resistance and extended-spectrum \u03b2-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin Microbiol Infect. 2004;10(1):72\u20135.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"630_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijmm.2014.12.001","volume":"305","author":"C L\u00fcbbert","year":"2015","unstructured":"L\u00fcbbert C, Straube L, Stein C, Makarewicz O, Schubert S, M\u00f6ssner J, et al. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol. 2015;305(1):148\u201356.","journal-title":"Int J Med Microbiol"},{"issue":"suppl1","key":"630_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/ecco-jcc\/jjx002.904","volume":"11","author":"V Skuja","year":"2017","unstructured":"Skuja V, Pekarska K, Straume Z, Rudz\u012bte D, Lavrinovi\u010da E, Piekuse L, et al. P783 ciprofloxacin resistance in ESBL producing enterobacteriaceae colonizing the gut in IBD patients. J Crohn\u2019s Colitis. 2017;11(suppl1):481\u2013S.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"3","key":"630_CR42","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/313719","volume":"30","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000;30(3):473\u20138.","journal-title":"Clin Infect Dis"},{"key":"630_CR43","doi-asserted-by":"crossref","unstructured":"Buchek G, Mende K, Telu K, Kaiser S, Fraser J, Mitra I et al. Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel. J Travel Med. 2021;28(3).","DOI":"10.1093\/jtm\/taab028"},{"issue":"3","key":"630_CR44","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1053\/j.gastro.2019.10.001","volume":"158","author":"V Dubinsky","year":"2020","unstructured":"Dubinsky V, Reshef L, Bar N, Keizer D, Golan N, Rabinowitz K, et al. Predominantly antibiotic-resistant intestinal microbiome persists in patients with Pouchitis who respond to antibiotic therapy. Gastroenterology. 2020;158(3):610\u201324e13.","journal-title":"Gastroenterology"},{"issue":"6","key":"630_CR45","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3892\/etm.2012.718","volume":"4","author":"SL Wang","year":"2012","unstructured":"Wang SL, Wang ZR, Yang CQ. Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Exp Ther Med. 2012;4(6):1051\u20136.","journal-title":"Exp Ther Med"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00630-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-023-00630-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00630-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T05:28:24Z","timestamp":1700371704000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-023-00630-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1186\/s12941-023-00630-x","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"19 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was reviewed and approved by the Institutional Ethical Review Committee of the Research Institute for Gastroenterology and Liver Diseases (RIGLD) at Shahid Beheshti University of Medical Sciences. The patients\/participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"86"}}